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THE USE OF HYALURONIDASE BY TONTOPHORESIS IN THE
TREATMENT OF GENERALIZED SCLERODERMA*
ROY J. POPKIN, M.D.
This is a preliminary report on the use of hyaluronidase in the treatment of
generalized scleroderma. The hyaluronidase was applied through iontophoresis.
This method of administration was selected as large areas of the body surface
could be treated without pain or discomfort.
Hyaluronidase (1, 2) is an enzyme prepared from bovine testes and other
sources which has the property of hydrolyzing hyaluronic acid. Hyaluronic acid
has a role in the formation of collagen. Its solutions are highly viscous. It exists
as a gel in many of the body tissues where it serves as a cement or ground sub-
stance between the cells and is a barrier to the diffusion of invasive substances.
On hydrolysis of hyaluronic acid by hyaluronidase, there is lessening of the
viscidity of the gel and a consequent reduction in the resistance of fluid ab-
sorption.
Because of the possible disturbance of the hyaluronidase-hyaluronic acid sys-
tem in scieroderma, either through a defect or deficiency in hyaluronidase pro-
duction or an excess of anti-hyaluronidase substance or of hyaluronic acid, the
following studies were undertaken.
METHOD AND MATEEIAL5
Iwo cases of chronic severe generalized scleroderma were treated. As tneie
were no reports in the literature as to the practicability of the application of
hyaluronidase by iontophoresis, considerable preliminary investigation was nec-
essary. Repeated studies were made on 6 normal persons and on 2 patients with
scleroderma to determine the most satisfactory technic for administration and
the effectiveness of transfer of the hyaluronidase from the active electrode into
the skin. After these were determined, treatment was instituted. Frequent ob-
servations were made during the period of treatment.
Hahn (3) in electrophoretic studies found that hyaluronidase at a pH of 5.2 was positively
charged and migrated from the anode to the cathode. Tint (4) in further investigations
found a pH of 5.4 more satisfactory for a greater degree of transfer. The following studies
were therefore made with the hyaluronidase dissolved in a .1 M acetate buffer solution
which had a pH of 5.4. At the onset, .1 mgm. of hyaluronidase (900 Turbidity reducing units
per mgm.) was applied. This was later increased to 1 mgm. of the same strength. Two mgm.
(1300 TRU/mgm.) was later used in treatment. The strength of the current and duration
of application were gradually increased from 3 milliamperes in 5 minutes to 15 milliamperes
for 15 minutes. It was found that 15 milliamperes for 15 minutes while satisfactory for the
cruder preparations of hyaluronidase created too much local heat and destroyed some of
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the more purified preparations. Seven milliamperes at 10 minutes were determined as the
optimum strength and time for treatments. All applications were made on the flexor surfaces
of the arms or forearms.
The opposite member was used as the control. No immediate systemic effects
were ever noted. The only immediate local effect was redness under the active
electrode. This would persist for as long as 2 hours. Occasionally hives similar
to those produced on histamine ionization were observed under this electrode.
These persisted for about 30 minutes. They differed from histamine in that itching
was not a feature. No subjective sensations were ever elicited except occasionally
a sensation of warmth at the active electrode during the application of current.
This was never great. It was usually present when the current was in excess of
10 milliamperes or over 10 minutes duration. The degree of hyaluronidase pene-
tration was determined by the disappearance time of a .1 cc. normal saline
intradermal-subdermal wheal. These were injected in the treated and untreated
opposite extremity which was used as a control. Twenty-five gauge needles were
used for the injections in all studies. With practice, exactly identical wheals were
raised in all individuals. Histamine wheals were also used but had to he discon-
tinued due to the pain created. Evans blue dye was occasionally used.
Initial studies were made with the acetate buffer solution alone at the positive
pole with currents ranging up to 10 milliamperes for 10 minutes. It was found
that the disappearance rate of the saline wheal on application of current with
the buffer solution alone as compared to a control area was similar, With the
higher currents, a slight increase in surface temperature was noted. When pres-
ent, this was confined to a very small area, usually about 2 cm. x 2 cm. The
vasodilatation never persisted beyond 30 minutes. Wheals placed in the center
of greatest vasodilatation did not show any difference in disappearance time.
Disappearance times varied between individuals from 20 minutes to over one
hour. They were consistent in each individual.
Increasing concentrations of hyaluronidase were applied in all cases at the
onset. Nine hundred turbidity reducing units per mgm. were used in the following
pilot studies.
.01 mgm., hyaluronidase, currents varying from 3 milliamperes in 5 minutes
to 10 milliamperes at 10 minutes. There was no difference in disappearance
time of the aline wheal in the treated or control areas.
.1 mgm. hyaluronidase. There was a slight increase in isolated instances of
the disappearance rate in the treated areas.
1 mgm. hyaluronidase. The wheal disappeared in the treated area in every
ease at a faster rate than the control area.
2 mgm. hyaluronidase. The wheal disappeared in every case in 25% of the
time taken in the control area.
In treatment, the initial applications were made with 1 mgm. of 900 turbidity
reducing units per mgm. dissolved in the buffer solution. This was later increased
to 2 mgm. of the 900 TRU/mgm. and later to 2 mgm. of 1300 TRU/mgm.
The following cases were treated:
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Case 1. Female, age 24, generalized scieroderma of 3 years duration, increasing in severity.
A total of 40 applications to the forearms were giveu over a period of 3 months. No untoward
reactions were noted. The disappearance rate of intradermal wheals in the treated area
and untreated control area was checked every 2 weeks. There was progressive decrease of
the disappearance time of the wheal in the treated areas. After a 6 weeks period of treat-
ment, the control area also showed a decrease in disappearance time but not as great as the
treated area. The skin throughout the body became softer. The waxy appearance decreased.
The sensitivity to cold decreased. This was the first time since the onset of the scleroderma
that the patient went through a winter without pain, stiffness, limitation of motion, Ray-
naud's syndrome or malaise. The sclerodactylia bilaterally and tightness in the treated
forearm were especially benefited. Although the greatest objective improvement was in
the treated area, subjective improvement was generalized. One tenth cc. intradermal .4%
Fm. 1. Before treatment
Evans blue was injected into the treated and control area after 12 applications and after 20
applications. In each instance, the area of dispersion of the dye was significantly greater
in the treated area. The area of dispersion was 30% greater in the treated area at the first
check. The second injection of Evans blue sho%ved a 50% greater dispersion in the treated
area as compared to the control area.
No further treatments were given for 9 months. As the mouth became constricted inter-
fering with nutrition and dental care, hyaluronidase was applied to the cheeks and about
the mouth. Alternate sides were treated at weekly intervals. At the onset, the maximum the
teeth could be separated on opening the mouth was 2.0 cms. and the lips 3.0 ems. After a
total of 18 applications given over a period of 4 months, the teeth could be separated by 2.3
ems. and the lips 4.5 ems. (Figs. 1—2). The sunken cheeks became full and normal facial
expression returned. The fluid content of the treated tissues appeared increased. The local
4k.
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improvement has persisted for 8 weeks following cessation of therapy. However, the selero-
dermatous process appeared to be progressing in the pnlmonary tissues as revealed by x-rays
and by subjective symptoms.
Case 2. Female, age 57, severe generalized scleroderma of 15 years duration with multiple
ulcerations and fiexion contractures of all the fingers. This patient also showed during her
course of treatment, a remarkable increase in the resistance to cold and increased general
well being. During the winter of administration of hyaluronidase, she was free of all the
uncomfortable symptoms of stiffness and Raynaud's syndrome that were previously
present. Softness of the skin and normal color retnrned. Considerable subjective relief has
been maintained for 9 months following cessation of therapy. She received 33 treatments
over a period of 3 months.
In each case, complete blood studies, urinalysis and x-ray studies of the hands and fingers
during the period of observation prodnced no significant changes.
Fin. 2. After 18 local applications of hyaluronidase
It was noted that towards the end of the original 3 months treatment, the effectiveness
of the hyaluronidase appeared to decrease in each case. Rotation of application sites cor-
rected this.
Within one week's cessation of treatment to the forearm, there was a partial return of
sensitivity to cold, malaise and of the saline wheal disappearance time to that observed
at the onset of treatment. The softness of the skin with the apparent increase in fluid content
persisted for several months. In neither case did the Raynaud's syndrome return in the
original severity.
DISCUSSION
The interpretation of the apparently good results is difficult to evaluate at
this time especially in view of the great number of substances which had been
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used in treatment previously and which also have been reported of benefit.
Treatment of scleroderma by iontophoresis is not new. Potassium iodide (5) and
mecholyl (6) have been applied by this method. Dihydrotachysterol (AT-b) (7),
promin (8) and ammonium chloride with benadryl (9) have also been reported
to be of value. Rarely have these substances or methods proven to be succes-
sful in hands other than their originators.
From the evidence obtained from these two cases of scleroderma, it appears
that a deficiency of hyaluronidase is one of the etiological factors. This fits in
with the current concept of a collagen disturbance in this disease. Some of the
pathological tissue changes in scleroderma appear to be reversible. The effects
of the hyaluronidase introduced by this method are not lasting. The results of
treatment appear promising. Many problems arise with the use of an enzyme.
Stability is difficult to maintain especially due to the factors of humidity, heat
and impurities. Other factors which probably also entered into this investigation
were: (a) A possible loss of hyaluronidase activator due to excessive purification.
This might have been a factor in the hyaluronidase administered later in treat-
ment when the more purified preparations were used. (b) Production of anti-
hyaluronidase by the tissue cells in frequent contact with the hyaluronidase.
This was avoided in later investigations by rotating the site of the active elec-
trode. (c) Destruction of the hyaluronidase at the active electrode through the
heat produced by the ionizing current. This was corrected by reducing the current
and time of application.
It is realized that the increased disappearance time of an intradermal and
subdermal saline wheal is not too accurate a method for the determination of
hyaluronidase. It is not a quantitative method. Other methods, however, were
not available. The increased disappearance time of the saline wheals closely
paralleled the clinical improvement.
SUMMARY
1. Hyaluronidase was effectively transferred into the tissues through the un
broken skin, of normals and of generalized scleroderma by iontophoresis. This
was proven by the increased disappearance rate of saline intradermal-subdermal
wheals and the increased area of dispersion of intradermal Evans blue dye.
2. Two cases of generalized scleroderma were treated with hyaluronidase ad-
ministered through iontophoresis for a period of 3 months vith clinical improve-
ment manifested by increased softness and flexibility of the tissues, decreased
sensitivity to cold, improvement in skin color and return of general well being.
On cessation of therapy, malaise and sensitivity to cold returned in one week;
improvement in tissue softness, flexibility and skin color persisted up to 3 months.
3. The beneficial effects of hyaluronidase in generalized scleroderma, a collagen
disease, substantiate the concept that there is a disturbance in the hyaluronidase-
hyaluronic acid system.
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